
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
Wegovy maker Novo sharpens consumer focus with board role for Mars CEO
Lily Allen 2026 'West End Girl' arena tour: How to get tickets, prices and more
Russia Creates New Military Branch Dedicated To Drone Warfare
The Fate of Rest: Patterns in Shrewd Beds
Remote Work Survival manual: Helping Efficiency at Home
Genesis Marks 10th Anniversary With Magma GT Concept Aimed at High-Performance Flagships
100 new alien worlds: Scientists find hidden haul in data from NASA exoplanet-hunting spacecraft
Day to day Temporary Positions That Compensate Fairly in the US













